3D Interaction,drug ligand name,target,Uniprot code,n_ca_T,n_ca_M,n_local_pairs,local_rmsd,local_coverage,vendor,smiles,clinical_phase,moa,database,cids,target chain id,chain name,Align Length,Binding_Affinity_kcal/mol
2E2B_406_P62343.pdb,406,2E2B,P62343,270,524,87,0.674,0.322,MedChemEx,CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncnc3)c2)C1,Phase 2,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,Uniprot,11387605,A,protein kinase [Plasmodium falciparum],229,-10.43
